EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms

Alexandra M Thomas, Ronald S Duman

Neuronal Signaling · 2017

DOI: 10.1042/ns20170010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuronal Signaling, 2017. Verfasst von Alexandra M Thomas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale University, New Haven, CT 06508, U.S.A. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a chronic, debilitating, and common illness. Currently available pharmacotherapies can be helpful but have several major drawbacks, including substantial rates of low or no response and a long therapeutic time lag. In pursuit of better treatment options, recent research has focussed on rapid-acting antidepressants, including the N-methyl-d-aspartate (NMDA) receptor (NMDAR) antagonist ketamine, which affects a range of signaling pathways in ways that are distinct from the mechanisms of typical antidepressants. Because ketamine and similar drugs hold the promise of dramatically improving treatment options for depressed patients, there has been considerable interest in developing new ways to understand how these compounds affect the brain. Here, we review the current understanding of how rapid-acting antidepressants function, including their effects on neuronal signaling pathways and neural circuits, and the research techniques being used to address these questions.

Autor:innen und Institutionen

  • Department of Psychiatry, Yale University, New Haven, CT 06508, U.S.A.

Förderung

  • NIMH NIH HHS

Zitieren

APA

Thomas, A. M., & Duman, R. S. (2017). Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms. Neuronal Signaling. https://doi.org/10.1042/ns20170010

Vancouver

Thomas AM, Duman RS. Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms. Neuronal Signaling. 2017. doi:10.1042/ns20170010

BibTeX
@article{Thomas2017,
  author = {Thomas, Alexandra M and Duman, Ronald S},
  title = {Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms},
  journal = {Neuronal Signaling},
  year = {2017},
  doi = {10.1042/ns20170010}
}
Kostenlos starten →